Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
(2025). Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction. EKB Journal Management System, 98(1), 971-976. doi: 10.21608/ejhm.2025.415889
. "Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction". EKB Journal Management System, 98, 1, 2025, 971-976. doi: 10.21608/ejhm.2025.415889
(2025). 'Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction', EKB Journal Management System, 98(1), pp. 971-976. doi: 10.21608/ejhm.2025.415889
Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction. EKB Journal Management System, 2025; 98(1): 971-976. doi: 10.21608/ejhm.2025.415889